Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.15 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |